A risk assessment framework was developed to evaluate the zoonotic potential of avian influenza (AI), focusing on virus mutations linked to phenotypic traits related to mammalian adaptation identified in the literature.

USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle.

In this 3-part podcast series, the International Federation on Ageing (IFA) aims to raise awareness of hMPV. The series will feature scientists, clinicians and the voices of older people and groups representing those most at risk of serious disease.

ESWI participated in the EU Flu Day at the European Parliament, an annual campaign organised by the Steering Group on Influenza Vaccination highlighting the importance of vaccines against influenza, COVID-19 and RSV.

Seasonal influenza poses a significant but often under-recognised challenge. The Steering Group on Influenza Vaccination is a group of academics, scientists, healthcare workers and civic society, advocating for increased flu vaccine uptake in Europe.

A new joint action focusing on tackling chronic respiratory diseases was recently launched. Backed by the EU4Health programme, the 3-year initiative aims to improve lung health across Europe through innovative digital health technologies.

Launched in Brussels on 30 January to drive political momentum for broader vaccine uptake across all stages of life. The group is co-chaired by Croatian MEP Tomislav Sokol and Lithuanian MEP Vytenis Andriukaitis, a former European Commissioner for Health.

The ESC Congress will be organised together with the World Congress of Cardiology in Madrid. This year's spotlight theme is "Global Health", emphasising the evolving role of cardiovascular disease within the broader global health landscape.

ECIM 2025 will feature a comprehensive scientific program, including keynote presentations, panel discussions, workshops, and networking opportunities.

Older adults, especially those over 65 years of age, face increased risks of immune senescence, chronic comorbidities, and decreased vaccine efficacy.

Viral variant and host vaccination status impact infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), yet how these factors shift cellular responses in the human nasal mucosa remains uncharacterized.

Health misinformation and disinformation are not new, but the COVID-19 pandemic marked a turning point. Health misinformation was weaponised as propaganda, exploiting fear, undermining public trust, and hindering collective action in critical moments.

Learn about the fascinating story behind the intriguing Human metapneumovirus (hMPV) and how it was first discovered.

A riveting episode from three unique perspectives on intervention strategies and the ongoing challenges posed by Sars-Cov-2, the virus behind one of the deadliest pandemics in recent history.

The series will delve into flu shots, RSV vaccines, COVID-19 boosters, and other kids on the block - what’s new and what’s in the pipeline

Tremendously exciting times and possibly underestimating the enormity of its impact. These are some of the comments we hear when experts share their insights on the recently available RSV vaccines.

The outbreak of high pathogenicity avian influenza (HPAI) in 2021–2022 is the likely primary driver of these declines.

Highly pathogenic avian influenza (HPAI) A(H5N1) continues to spread throughout domestic poultry and cattle, with occasional transmission to humans.

In 2021, a highly pathogenic influenza H5N1 clade 2.3.4.4b virus was detected in North America that is capable of infecting a diversity of avian species, marine mammals, and humans.

Highly pathogenic avian influenza (HPAI) A(H5N1) emerged in 1997.1 Since then, it has spread globally by migratory birds, resulting in infections in animals on every continent.